Public Employees Retirement Association of Colorado boosted its position in TESARO, Inc. (NASDAQ:TSRO) by 16.8% during the second quarter, Holdings Channel reports. The fund owned 8,109 shares of the biopharmaceutical company’s stock after buying an additional 1,167 shares during the period. Public Employees Retirement Association of Colorado’s holdings in TESARO were worth $1,134,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Vident Investment Advisory LLC purchased a new stake in TESARO during the first quarter worth $351,000. Meeder Asset Management Inc. purchased a new stake in TESARO during the first quarter worth $177,000. Fox Run Management L.L.C. purchased a new stake in TESARO during the second quarter worth $224,000. Private Capital Advisors Inc. purchased a new stake in TESARO during the second quarter worth $232,000. Finally, Soros Fund Management LLC purchased a new stake in TESARO during the first quarter worth $262,000.

Shares of TESARO, Inc. (TSRO) opened at 113.25 on Tuesday. The firm has a 50-day moving average price of $129.50 and a 200 day moving average price of $148.97. The company’s market cap is $6.14 billion. TESARO, Inc. has a 1-year low of $83.26 and a 1-year high of $192.94.

TESARO (NASDAQ:TSRO) last announced its earnings results on Tuesday, August 8th. The biopharmaceutical company reported ($2.82) earnings per share for the quarter, missing analysts’ consensus estimates of ($2.52) by $0.30. TESARO had a negative return on equity of 104.00% and a negative net margin of 1,301.19%. The business had revenue of $29.50 million during the quarter, compared to analysts’ expectations of $18.61 million. During the same quarter in the previous year, the firm earned ($1.28) EPS. TESARO’s quarterly revenue was down 17.6% on a year-over-year basis. On average, analysts predict that TESARO, Inc. will post ($8.66) EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/public-employees-retirement-association-of-colorado-purchases-1167-shares-of-tesaro-inc-tsro/1488534.html.

A number of equities research analysts have recently weighed in on the company. Robert W. Baird restated a “neutral” rating and set a $140.00 target price (down previously from $155.00) on shares of TESARO in a research report on Thursday, August 10th. Janney Montgomery Scott set a $139.00 price objective on TESARO and gave the stock a “hold” rating in a research note on Saturday, June 10th. Morgan Stanley reaffirmed an “overweight” rating and set a $183.00 price objective on shares of TESARO in a research note on Thursday, August 10th. Cowen and Company set a $145.00 price objective on TESARO and gave the stock a “hold” rating in a research note on Saturday, June 10th. Finally, ValuEngine raised TESARO from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $176.35.

In other news, VP Edward C. English sold 8,500 shares of the business’s stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $138.65, for a total value of $1,178,525.00. Following the transaction, the vice president now owns 5,396 shares in the company, valued at approximately $748,155.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 34.60% of the stock is owned by insiders.

About TESARO

TESARO, Inc is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

Want to see what other hedge funds are holding TSRO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TESARO, Inc. (NASDAQ:TSRO).

Institutional Ownership by Quarter for TESARO (NASDAQ:TSRO)

Receive News & Ratings for TESARO Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TESARO Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.